Home » Topics » BioWorld Science

BioWorld Science
RSS

CF-370 shows synergy with amikacin in drug-resistant P. aeruginosa acute pneumonia model

May 2, 2022

Innate immune memory underlies inflammatory comorbidities: study

May 2, 2022

New mucolipin-1 activators identified at Lysoway Therapeutics

May 2, 2022

Curome Biosciences presents new quinone derivatives

May 2, 2022

Vertex Pharmaceuticals discovers CFTR modulators

May 2, 2022

New KCNA3 channel blockers identified at DE Shaw Research

May 2, 2022

Bristol Myers Squibb describes new FPR1/2 agonists

May 2, 2022

BBT-207, a fourth-generation EGFR TKI with activity against most common mutants

May 2, 2022

Chimera Bioengineering advances preclinical testing of CAR-T therapy CBIO-007 for solid tumors

April 29, 2022

HanAll advances novel immuno-oncology antibodies HL-187/HL-186

April 29, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...